Jeffrey Robert Ajer - Mar 29, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 29, 2022
Transactions value $
-$238,390
Form type
4
Date filed
3/31/2022, 09:28 PM
Previous filing
Mar 24, 2022
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$129K -1.62K -2.73% $79.43 57.6K Mar 29, 2022 Direct F1
transaction BMRN Common Stock Sale -$110K -1.38K -2.4% $79.56 56.3K Mar 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.